Published in Nature on January 23, 2017
Epidemiological Landscape of Cervical Cancer in Latin America (EVITA LATAM) | NCT04947605
Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer (2017) 0.80
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia (2017) 0.76
Comparative transcriptomes of adenocarcinomas and squamous cell carcinomas reveal molecular similarities that span classical anatomic boundaries. PLoS Genet (2017) 0.76
Gynaecological cancer: Novel molecular subtypes of cervical cancer - potential clinical consequences. Nat Rev Clin Oncol (2017) 0.75
Analysis of Class I Major Histocompatibility Complex Gene Transcription in Human Tumors Caused by Human Papillomavirus Infection. Viruses (2017) 0.75
Cervical Cancer Neoantigen Landscape and Immune Activity is Associated with Human Papillomavirus Master Regulators. Front Immunol (2017) 0.75
Computational Methods for Characterizing Cancer Mutational Heterogeneity. Front Genet (2017) 0.75
Molecular mechanisms of human papillomavirus-related carcinogenesis in head and neck cancer. Microbes Infect (2017) 0.75
MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis. BMC Cancer (2017) 0.75
A Comprehensive Infrastructure for Big Data in Cancer Research: Accelerating Cancer Research and Precision Medicine. Front Cell Dev Biol (2017) 0.75
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol (2009) 235.12
TopHat: discovering splice junctions with RNA-Seq. Bioinformatics (2009) 81.13
Integrated genomic analyses of ovarian carcinoma. Nature (2011) 47.72
Comprehensive molecular portraits of human breast tumours. Nature (2012) 47.39
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer (2014) 40.30
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics (2011) 25.76
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol (2008) 24.27
Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics (2004) 24.18
Signatures of mutational processes in human cancer. Nature (2013) 21.63
Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature (2013) 20.16
Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat Genet (2008) 19.55
Comprehensive genomic characterization of squamous cell lung cancers. Nature (2012) 18.90
BreakDancer: an algorithm for high-resolution mapping of genomic structural variation. Nat Methods (2009) 18.41
Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. Nat Genet (2008) 15.89
Integrated genomic characterization of endometrial carcinoma. Nature (2013) 14.29
Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol (2012) 10.87
High density DNA methylation array with single CpG site resolution. Genomics (2011) 10.35
MapSplice: accurate mapping of RNA-seq reads for splice junction discovery. Nucleic Acids Res (2010) 9.80
GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol (2011) 9.60
Comprehensive molecular characterization of urothelial bladder carcinoma. Nature (2014) 8.48
Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM. Bioinformatics (2010) 8.44
TGFβ signalling in context. Nat Rev Mol Cell Biol (2012) 8.08
Mutual exclusivity analysis identifies oncogenic network modules. Genome Res (2011) 7.22
14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell (1997) 7.20
Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci U S A (2010) 6.15
Integrated genomic characterization of papillary thyroid carcinoma. Cell (2014) 6.05
Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature (2015) 5.50
Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer (2010) 4.99
An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat Genet (2013) 4.69
Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst (2011) 4.59
Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis. Bioinformatics (2009) 4.21
miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions. Nucleic Acids Res (2013) 4.19
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell (2014) 4.17
Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell (2015) 4.16
The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat Med (2013) 3.96
Evidence for APOBEC3B mutagenesis in multiple human cancers. Nat Genet (2013) 3.94
PathSeq: software to identify or discover microbes by deep sequencing of human tissue. Nat Biotechnol (2011) 3.57
An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clin Cancer Res (2012) 3.48
KRAS and YAP1 converge to regulate EMT and tumor survival. Cell (2014) 3.06
The role of the ZEB family of transcription factors in development and disease. Cell Mol Life Sci (2009) 2.95
Landscape of genomic alterations in cervical carcinomas. Nature (2013) 2.61
A pan-cancer proteomic perspective on The Cancer Genome Atlas. Nat Commun (2014) 2.25
Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res (2004) 2.24
Oncogenic ERBB3 mutations in human cancers. Cancer Cell (2013) 2.06
Diverse mechanisms of somatic structural variations in human cancer genomes. Cell (2013) 2.00
A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res (2010) 1.82
Downregulation of 14-3-3sigma prevents clonal evolution and leads to immortalization of primary human keratinocytes. J Cell Biol (2000) 1.81
EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer. BMC Cancer (2012) 1.70
APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development. Cell Rep (2014) 1.50
UM-SCC-104: a new human papillomavirus-16-positive cancer stem cell-containing head and neck squamous cell carcinoma cell line. Head Neck (2011) 1.45
The papillomavirus E7 proteins. Virology (2013) 1.28
Papillomavirus E6 oncoproteins. Virology (2013) 1.21
MicroRNAs regulate both epithelial-to-mesenchymal transition and cancer stem cells. Oncogene (2013) 1.20
Transforming RNA-Seq data to improve the performance of prognostic gene signatures. PLoS One (2014) 1.10
A systems-level integrative framework for genome-wide DNA methylation and gene expression data identifies differential gene expression modules under epigenetic control. Bioinformatics (2014) 1.09
BioBloom tools: fast, accurate and memory-efficient host species sequence screening using bloom filters. Bioinformatics (2014) 1.08
Molecular transitions from papillomavirus infection to cervical precancer and cancer: Role of stromal estrogen receptor signaling. Proc Natl Acad Sci U S A (2015) 1.06
Epigenetic control of epithelial-mesenchymal-transition in human cancer. Mol Clin Oncol (2012) 1.03
Expression of the tumor suppressor protein 14-3-3 sigma is down-regulated in invasive transitional cell carcinomas of the urinary bladder undergoing epithelial-to-mesenchymal transition. Mol Cell Proteomics (2004) 1.00
A core microRNA signature associated with inducers of the epithelial-to-mesenchymal transition. J Pathol (2014) 0.95
14-3-3σ regulates β-catenin-mediated mouse embryonic stem cell proliferation by sequestering GSK-3β. PLoS One (2012) 0.94
Genomic aberrations in cervical adenocarcinomas in Hong Kong Chinese women. Int J Cancer (2015) 0.89
Microenvironment-dependent cues trigger miRNA-regulated feedback loop to facilitate the EMT/MET switch. J Clin Invest (2014) 0.88
Learning subgroup-specific regulatory interactions and regulator independence with PARADIGM. Bioinformatics (2013) 0.87
BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib. Br J Cancer (2012) 0.87
Oncogenes: All eyes on YAP1. Nat Rev Cancer (2014) 0.79
Genomics of cervical cancer and the role of human papillomavirus pathobiology. Clin Chem (2013) 0.78
Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature (2008) 75.40
Integrated genomic analyses of ovarian carcinoma. Nature (2011) 47.72
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell (2010) 39.09
The UCSC Genome Browser Database. Nucleic Acids Res (2003) 32.84
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med (2013) 19.87
Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell (2010) 16.12
Integrated genomic characterization of endometrial carcinoma. Nature (2013) 14.29
Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature (2013) 13.60
Comprehensive molecular characterization of gastric adenocarcinoma. Nature (2014) 11.93
Comprehensive molecular profiling of lung adenocarcinoma. Nature (2014) 11.02
Charting a course for genomic medicine from base pairs to bedside. Nature (2011) 9.39
Comprehensive molecular characterization of urothelial bladder carcinoma. Nature (2014) 8.48
Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. J Nucl Med (2006) 7.40
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med (2015) 5.71
Landscape of somatic retrotransposition in human cancers. Science (2012) 4.37
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell (2014) 4.17
Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. JAMA (2012) 3.85
Prognostically relevant gene signatures of high-grade serous ovarian carcinoma. J Clin Invest (2012) 3.64
Prognostic and predictive roles of high-degree microsatellite instability in colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project Collaborative Study. J Clin Oncol (2007) 3.51
The Molecular Taxonomy of Primary Prostate Cancer. Cell (2015) 3.29
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med (2015) 3.00
Integrated genomic characterization of oesophageal carcinoma. Nature (2017) 2.76
Trastuzumab, paclitaxel, carboplatin, and gemcitabine in advanced human epidermal growth factor receptor-2/neu-positive urothelial carcinoma: results of a multicenter phase II National Cancer Institute trial. J Clin Oncol (2007) 2.36
The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell (2014) 2.21
Integrating patient-reported outcomes into cancer symptom management clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. J Clin Oncol (2007) 1.98
Treatment tolerance and efficacy in geriatric oncology: a systematic review of phase III randomized trials conducted by five National Cancer Institute-sponsored cooperative groups. J Clin Oncol (2007) 1.86
Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma. PLoS One (2012) 1.76
Spectrum of somatic mitochondrial mutations in five cancers. Proc Natl Acad Sci U S A (2012) 1.63
Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. J Clin Oncol (2007) 1.27
Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nat Genet (2016) 1.16
Continuous quality improvement: DOQI becomes K/DOQI and is updated. National Kidney Foundation's Dialysis Outcomes Quality Initiative. Am J Kidney Dis (2001) 1.14
Health-related quality of life and symptom management research sponsored by the National Cancer Institute. J Clin Oncol (2007) 1.09
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell (2016) 1.06
Opportunities and challenges in the era of molecularly targeted agents and radiation therapy. J Natl Cancer Inst (2013) 0.93
Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell (2017) 0.92
Update: Interim Guidance for the Evaluation and Management of Infants with Possible Congenital Zika Virus Infection - United States, August 2016. MMWR Morb Mortal Wkly Rep (2016) 0.90
Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: a collaborative Children's Oncology Group/National Cancer Institute pilot trial (CCG-1942). Pediatr Blood Cancer (2007) 0.89
Summary report: early reproductive events and breast cancer workshop. Issues Law Med (2005) 0.88
A summary of evidence on radiation exposures received near to the Semipalatinsk nuclear weapons test site in Kazakhstan. Health Phys (2003) 0.81
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell (2017) 0.81
Mental health professionals in North Carolina. N C Med J (2008) 0.81
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. Cancer Cell (2017) 0.79
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. Cancer Cell (2016) 0.76
[Rectal cancer Information dedicated to cancer patients and relatives]. Bull Cancer (2006) 0.75
Sepsis Endotypes Defined By Cytokine Trajectory Analysis. Intensive Care Med Exp (2015) 0.75
Cancer facts: abortion, miscarriage, and breast cancer risk. Issues Law Med (2005) 0.75
[Social aspects and cancer: information dedicated to cancer patients and relatives]. Bull Cancer (2005) 0.75
Which adults should be tested or treated for vitamin D deficiency? J Okla State Med Assoc (2009) 0.75
NIH to map changes of 3 cancers. J Nucl Med (2006) 0.75
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Cancer Cell (2017) 0.75